Results 31 to 40 of about 21,329 (69)

FREQUENCY OF RISK FACTORS FOR DEVELOPMENT OF METABOLIC FATTY LIVER DISEASE (MAFLD) IN A CENTER OF CONCENTRATION OF LIVER DISEASES

Annals of Hepatology, 2022
Introduction and Objectives: Metabolic fatty liver disease (MAFLD) includes a wide spectrum of presentations, ranging from simple steatosis and non-alcoholic steatohepatitis to liver cirrhosis, leading to hepatocellular carcinoma; the etiology of this is
S. Tellez-Jaen, G. López-Rodríguez, R. Contreras-Omaña, M.A González-Unzaga   +3 more
doaj   +1 more source

DIFFERENTIAL PROFILE OF PRO-INFLAMMATSORY / ANTI-INFLAMMATORY CYTOKINES AND MALONDIALDEHYDE IN PATIENTS WITH ALCOtHOL-INDUCED OR OBESITY OR MIXED INJURY

Annals of Hepatology, 2022
Introduction and Objectives: Dysregulation of pro-inflammatory/anti-inflammatory cytokines and oxidative stress markers has been reported in Non-Alcoholic Steatohepatitis (NASH) and alcoholic steatohepatitis (ASH); however, in the disease recently known,
L. Torres-González, L.R. Aguilar Rivera, D.P. Moreno-Peña, O.H. Mendoza Hernández, A.A. Lugo Rodriguez, M.E. Posada Lerma, L.E. Muñoz Espinosa, H. Nañez Terreros, P. Cordero-Pérez   +8 more
doaj   +1 more source

Distribution of bone thickness in the human mandibular ramus – a CBCT-based study

Head & Face Medicine, 2020
Background The bone thickness of the human mandibular ramus is an important parameter in mandibular surgeries. The aim of this study was to systematically measure the bicortical bone thickness, the ramus dimensions and the position of the lingula.
K. Kronseder, C. Runte, J. Kleinheinz, S. Jung, D. Dirksen   +4 more
doaj   +1 more source

HGF AND PROTECTIVE ROLL IN THE INTESTINAL COLLATERAL DAMAGE BY Α-NAFTILISOTIOCIANATO- INDUCE CHOLESTASIS.

Annals of Hepatology, 2022
Introduction and Objectives: he prevalence of cholestasis has been increasing in recent years; The excretion of bile acids via basolateral has been demonstrated to prevent the excessive accumulation in the hepatocyte, and the liver-intestine axis has ...
J. Lopez-Ramirez, M. García-Barrera, N. Nuño-Lámbarri, S. Salas-Silva, M.C. Gutiérrez-Ruiz, V. Souza, L.E. Gomez-Quiroz, L. Bucio Ortiz   +7 more
doaj   +1 more source

IGFBP-1 TO 7 AS BIOMARKERS IN STAGES OF LIVER FIBROSIS DURING VIRAL HEPATITIS C

Annals of Hepatology, 2022
Introduction and Objectives: Diagnosis of liver disease (LD) is essential for the treatment and management of patients. The use of non-invasive methodologies is necessary despite the availability of direct-acting antivirals, some reports has been showed ...
M. Martínez-Castillo, D. Santana-Vargas, J.L. Pérez-Hernández, F. Higuera-De la Tijera, D. Kershenobich, G. Gutiérrez-Reyes   +5 more
doaj   +1 more source

Association of Triglyceride-Glucose Index with Risk of Large for Gestational Age: A Prospective Cohort Study [Letter]

Diabetes, Metabolic Syndrome and Obesity, 2023
Slamet Wardoyo,1 Khayan Khayan,2 Taufik Anwar3 1Department of Environmental Health, Poltekkes Kemenkes Surabaya, Surabaya, Indonesia; 2Department of Medical Laboratory Technology, Poltekkes Kemenkes Banten, Serang, Indonesia; 3Department of Environmental
Wardoyo S, Khayan K, Anwar T
doaj  

Global real-world evidence of sofosbuvir/velpatasvir (SOF/VEL) as a highly effective treatment in underserved patient populations because of mental health disorders, incarceration or homelessness

Annals of Hepatology, 2022
Introduction and Objectives: The treatment of vulnerable populations must be prioritized to accomplish the WHO HCV elimination goals by 2030, including patients with mental health disorders, incarcerated patients or homeless patients.
L. Barrett, S. Rosati, M. Garcia-Retortillo, H. Wedemeyer, E. Teti, FA Pérez Hernández, M. Selfridge, A. Wong, S. Rodriguez-Tajes, L.E. Morano-Amado, C. Brixko, E. Jimenez-Mutiloa, J. O'Loan, M. Milella, F. Campanale, G. Macedo, M. Guerra-Veloz, I. Maida, R. Ranieri, A. Martins, A. Bascia, M. Buti, C.M. Fernandez-Rodriguez, B. Conway, J. Foucher, S. Fagiuoli, A. Ramji, M. Fenech, P. Ryan, S. Borgia, A. Mangia, J. Mendez-Navarro, I. Ntalla, C. Hernández, M. Mertens, K. Vanstraelen, V. Calvaruso   +36 more
doaj   +1 more source

Obesity Patterns, Metabolic Abnormality, and Diabetic Kidney Disease in Patients with Type 2 Diabetes

Diabetes, Metabolic Syndrome and Obesity, 2023
Kun Zhang, Wen Zhang, Fangzhen Xia, Ningjian Wang, Yingli Lu, Chunhua Sui, Bin Wang Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, People’s ...
Zhang K, Zhang W, Xia F, Wang N, Lu Y, Sui C, Wang B   +6 more
doaj  

FRUCTOSE DIET INDUCES A METABOLIC REPROGRAMMING TO ENHANCE TUMOR AGGRESSIVENESS

Annals of Hepatology, 2022
Introduction and Objectives: HCC is one of the main causes of cancer-related death worldwide and has third place in mortality. One of the main risk factors is metabolic-associated fatty liver disease (MAFLD), having hepatic steatosis, and related ...
L. Chávez-Rodríguez, A. Escobedo-Calvario, A. Simoni-Nieves, L. Bucio, V. Souza, R.U. Miranda Labra, G.C. Enriquez-Cortina, F. Masso, A. Páez Arenas, D.F. Calvisi, M.C. Gutiérrez-Ruíz, L.E. Gómez-Quiroz   +11 more
doaj   +1 more source

Association Between Different Metabolic Markers and Metabolic Syndrome in an Outpatient Hyperuricemia Population: A Cross-Sectional Study

Diabetes, Metabolic Syndrome and Obesity, 2023
Xin Li,* Bo Huang,* Yue Liu, Meng Wang, Yi-Xuan Wang, Kai-Lei Feng, Jing-Qiu Cui Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China*These authors contributed equally to
Li X, Huang B, Liu Y, Wang M, Wang YX, Feng KL, Cui JQ   +6 more
doaj